当前位置：首页 > 文献互助 > 互助详情

Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders复制

用户6X7Ch8WUQ_gI 2小时前 11 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-10-14 21:35:47 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1021/acs.jmedchem.5c00540复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00540复制

其他信息:

出版社: American Chemical Society (ACS)
作者: Santosh Kumar Rai; Rakesh Ishwar Patil; Sazid Ali; Rakesh Kumar; Mohd Imran Khan; Amit Panwar; Srinivasa Reddy; Muneeb Ahsan; Sunil Iyer; Anil Kumar
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c00540

上一篇：Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760

下一篇：Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754

互助时间线

2025-10-07 21:37:26 [完结求助]

楼主确认了A123B应助的文件是正确的, 求助状态变成 已完结

2025-10-07 21:35:47 [上传文件]

A123B上传了文件(pdf 3.08 MB), 求助状态变成 待确认

2025-10-07 21:35:41 [发起求助]

最新发布的求助

GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management 25分钟前
Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754 1小时前
Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders 2小时前
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760 2小时前
A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded Library 2小时前
Selective electrochemical synthesis of urea from nitrate and CO2 via relay catalysis on hybrid catalysts 3小时前
Large-scale deployment of single-atom catalysts via cross-scale confinement in ceramic membranes for advanced water treatment 3小时前
Near-Infrared-Triggered Self-Healing and Antibacterial Biobased Waterborne Polyurethane Enabled by Porphyrin Covalent Organic Frameworks 14小时前
Terpenoids and Steroids, V. 7: A Review of the Literature Published Between September 1975 and August 1976 1天前
Development of Novel PTPN2/1 Inhibitors for the Treatment of Melanoma 1天前
Discovery, Optimization, and Anticancer Activity of Lipid-Competitive Pleckstrin Homology Domain-Containing Family A Inhibitors 1天前
Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer 1天前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com